-
Published05/12/2024
-
Deadline08/01/2025
-
Opening of tenders08/01/2025
-
Today13/01/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Drug supply - Active substance pazopanib - ATC L01EX03 Text automatically translated in your browsing language Automatically translated
The subject of the contract is the continuous supply of a medicinal product containing the active substance pazopanib – ATC L01EX03. LL - pazopanib, pharmaceutical form 200MG TBL FLM 30, unit of measurement 30X200MG, quantity 400 LL - pazopanib, pharmaceutical form 400MG TBL FLM 60, unit of measurement 60X400MG, quantity 1 100 Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
33652100 - Antineoplastic agents
33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.